Welcome Guest
Sign In
Register
Research & Development
Quality
Regulatory
Manufacturing
Home
News
Articles
MAGAZINE
Resources
Sponsored Q&A
Whitepapers
eBooks
Infographics
Videos
Webinars
Products
Featured Products
New Products
Events
FAQ
Featured Article
Reaping the spoils of CGT’s golden age
LATEST ARTICLES
Visible particulates in cell therapy: Industry looks toward a more realistic ...
Navigating material demands of next-gen CGTs
Electroporation-based delivery for gene editing
Preclinical roadmap to first-in-human
Swimming upstream
2026 cell and gene therapy predictions
LATEST NEWS
Kyverna autoimmune CAR-T aces stiff person syndrome trial
Wednesday, April 22, 2026
Lilly to buy Kelonia for $3.5B, advancing in vivo CAR-T
Monday, April 20, 2026
UCB buys Neurona for $1.15B, betting on epilepsy cell therapy
Monday, April 20, 2026
CPC Biopharma, PSG Biotech launch new combined entity
Friday, April 17, 2026
J&J returns eye disease gene therapy to MeiraGTx
Friday, April 17, 2026
Eyeing EU approval, Roche plans new phase 3 Elevidys study
Friday, April 17, 2026
First patients dosed with Cabaletta CAR-T made on Cellares automated platform
Wednesday, April 15, 2026
Subscribe to eNewsletters
Keep up with latest in cell and gene therapy news and events, delivered straight to your inbox.
Connect with Us
Subscribe to Magazine
Jan/Feb/Mar 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »
Upcoming Events
INTERPHEX 2026
April 21-23, 2026
Meeting on the Med 2026
April 28-30, 2026
TRI-CON 2026: Entering the Age of AI
May 4-5, 2026
Featured Products
HyClone™ Peak Expression Media
Cytiva
Fetal Bovine Serum, 500 mL, Australian Origin
Corning
LevMixer™ 10 L Single-use Mixing System
Cytiva
ProteanFect™ TuffCell Transfection Kit
Origene
Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing Kit
Thermo Fisher Scientific
Corning® MSCulture Max™ Media
Corning
Xcellerex™ X-platform bioreactors
Cytiva
Dual AAV-GFP Controls
Vector Biolabs